Colorectal Cancer Clinical Trial
Official title:
Comparison of Preoperative Multimodal Preparation Program (Prehabilitation) With Enhanced Recovery Program for Elective Colorectal Cancer Surgery.
Elective surgery is the most effective treatment option for colorectal cancer, however it has
been recognized to be associated with high morbidity and mortality risks.
ERAS (Enhanced Recovery After Surgery) is a preoperative multimodality treatment package,
which has been well investigated and proved to be effective in reducing early postoperative
morbidity, mortality, length of hospital stay and hospital costs, as well. Still, a good
proportion of patients are not suitable for ERAS program, mainly based on lack of compliance
and the impaired physical function before surgery.
Prehabilitation Program is a recently introduced trimodal preoperative preparation (training)
program, which addresses improvement of physical, mental and nutritional status of the high
risk elective surgery patients.
This study aims to investigate the benefit of all efforts of a 4-6-week preoperative
preparation program (Prehabilitation) being added to an established ERAS protocol.
Aim:
Colorectal cancer patients with a planned resection are tested if a complex, trimodal
rehabilitation program can hold functional and morbidity benefit for them.
In the prospective, randomized (1:1) study control patient group will be the well established
and tested ERAS (enhanced recovery after surgery) Program.
Study protocol in details:
1. First visit: Outpatient Department of Surgery
On both arms:
• History taking (including family history and oncologic history);
• Physical examination
- Operation indication, type of procedure and date of procedure agreed;
- Organizing further investigations, anesthesia;
- Operative risk assessment ("ACS - surgical risk calculator");
- Study patient identifier Nr generated;
2. Nurse-led ERAS/Prehab clinic: randomization
On both arms:
- Randomization (Prehabilitation Program / ERAS Program).
- Nurse led clinic assessment ("study nurse"):
.i. CaseReportForm (CRF) filled in.
.ii. Patient data (personal data, demographics, history) .iii. Anthropometrics (BMI,
MUST, Body fat % measurement). .iv. Mental hygienic status assessment (smoking, alcohol
consumption, anxiety, depression, sleeping disorders).
.v. Cardiovascular status (resting HR, RR). .vi. Operative risk assessment (CR-Possum
score). .vii. Preoperative counseling (operation type, preparation, pain management,
discharge plan).
.viii. Preoperative nutritional planning (education, nutrient prescription). .ix.
Alcohol intake and smoking cessation - information given. .x. Stoma education started.
.xi. Consent signed, patient workbook handed over. .xii. Respiratory test referral.
3. Physiotherapy, first visit
Both on control and interventional arms:
- Respiratory function test recorded.
- Physical status tested (6MWD) on a treadmill.
Just on Prehabilitation arm:
• Respiratory training education.
- Respiratory trainer device usage educated.
- Daily activity (walking) planned.
4. Physiotherapy - second/third/fourth visit (weekly)
Just on Prehabilitation arm:
• Previous week activity reviewed as to workbook.
• Physical assessment: 6MWD, FVC.
• Next week activity planned.
5. Psychic preparation
Just on Prehabilitation arm:
- Once a week half an hour group relaxation training - regardless of the stage of
prehabilitation program.
6. Admission to the Surgical Ward a day before surgery
Both on control and interventional arm:
- Preoperative assessment:
.i. Anthropometrics (BMI, body fat%). .ii. Cardiovascular stage (resting HR and RR),
ECG. .iii. Respiratory function tests. .iv. Physical status (6MWD) .v. Mental status
(Hospital Anxiety and Depression Scale (HADS)) assessment.
- Preoperative preparation (as to ERAS protocol).
- Postoperative care (ITU, pain management, mobilization, oral nutrition built up,
drains early removal, complications recorded (Clavien-Dindo-classification)).
- Stoma education.
- Dietary education.
- On discharge: Quality of Life (QoL) SF36 - (36-Item Short Form Survey from the RAND
Medical Outcomes Study).
7. Postoperative follow up:
Both on control and interventional arms:
• Assessment (4th and 8th week post op.):
.i. Anthropometrics (BMI, Body fat %) .ii. Cardiovascular status (resting HR and RR). .iii.
Respiratory function tests. .iv. Physical status (6MWD).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |